Lisa Derosa
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Biological Psychiatry top 1%
Papers in
- Oncology 61
- Cancer Immunotherapy and Biomarkers 43
- Pancreatic and Hepatic Oncology Research 12
-
- Renal cell carcinoma treatment 30
- Prostate Cancer Treatment and Research 14
- Co-authors
- laurence ZITVOGEL (31 shared papers)Bertrand Routy (9 shared papers)Guido Kroemer (14 shared papers)Bernard J. Escudier (24 shared papers)Laurence K. Albiges (28 shared papers)Arielle Elkrief (6 shared papers)Bertrand Routy (8 shared papers)Marine Fidelle (4 shared papers)
In The Last Decade
Lisa Derosa
134 papers receiving 13.5k citations
Lisa Derosa's Hit Papers
Peers
Comparison fields: 5 of 142
- Oncology 5.3k
- Biological Psychiatry 461
- Infectious Diseases 2.0k
- Immunology 2.2k
- Molecular Biology 6.4k
Countries citing papers authored by Lisa Derosa
This map shows the geographic impact of Lisa Derosa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Derosa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Derosa more than expected).
Fields of papers citing papers by Lisa Derosa
This network shows the impact of papers produced by Lisa Derosa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Derosa. The network helps show where Lisa Derosa may publish in the future.
Co-authors
The 25 scholars most cited alongside Lisa Derosa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 142 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors Hit paper breakdown → | 2017 | 4482 |
| 2 | Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer Hit paper breakdown → | 2018 | 735 |
| 3 | Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19 Hit paper breakdown → | 2020 | 620 |
| 4 | Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer Hit paper breakdown → | 2022 | 536 |
| 5 | Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease Hit paper breakdown → | 2021 | 466 |
| 6 | Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial Hit paper breakdown → | 2023 | 378 |
| 7 | Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade Hit paper breakdown → | 2021 | 349 |
| 8 | Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma Hit paper breakdown → | 2022 | 346 |
| 9 | Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade Hit paper breakdown → | 2020 | 328 |
| 10 | Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage Hit paper breakdown → | 2020 | 325 |
| 11 | 2020 | 314 | |
| 12 | 2020 | 258 | |
| 13 | 2016 | 251 | |
| 14 | 2019 | 205 | |
| 15 | 2020 | 170 | |
| 16 | A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers Hit paper breakdown → | 2023 | 169 |
| 17 | 2020 | 146 | |
| 18 | 2014 | 145 | |
| 19 | 2016 | 136 | |
| 20 | 2021 | 135 |
About Lisa Derosa
Lisa Derosa is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Biological Psychiatry and Infectious Diseases, having authored 142 papers that have together received 13.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (43 papers), Gut microbiota and health (40 papers), Renal cell carcinoma treatment (30 papers), Prostate Cancer Treatment and Research (14 papers), Pancreatic and Hepatic Oncology Research (12 papers), Cancer Genomics and Diagnostics (8 papers), Tryptophan and brain disorders (8 papers) and Renal and related cancers (7 papers). The work is most often cited by research in Oncology (5.3k citations), Biological Psychiatry (461 citations), Infectious Diseases (2.0k citations), Immunology (2.2k citations) and Molecular Biology (6.4k citations). Lisa Derosa has collaborated with scholars based in France, Italy and Canada. Frequent co-authors include laurence ZITVOGEL, Bertrand Routy, Guido Kroemer, Bernard J. Escudier, Laurence K. Albiges, Arielle Elkrief, Bertrand Routy, Marine Fidelle, Matthew David Hellmann and Luca Galli. Their work appears in journals such as Annals of Oncology, Nature Medicine, OncoImmunology, Oncotarget and Clinical Genitourinary Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.